PCSK9 and gastric cancer: In syngeneic mouse models of gastric cancer, PCSK9 inhibition was demonstrated to upregulate DC infiltration and tumor cell MHC-II expression and subsequently enhance CD8+ T cell activation to realize potent tumor repression.